Newsbenzinga
GSK Enters Agreement To Acquire Nuvalent For $10.6B At $124 Per Share, A 40% Premium To Last Closing Price
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…